Trazodone Misuse: Withdrawal, Overdose, Interactions, and Treatment

Trazodone is a prescription antidepressant that commonly causes sedation and can be misused, but prescribed use, discontinuation symptoms, and substance use disorder are not interchangeable. Clinicians assess impaired control, compulsive use, continued harm, and functional consequences when misuse becomes a treatment concern.

A person who cannot be awakened, has trouble breathing, collapses, has a seizure, or may have taken too much trazodone needs immediate poison-center or emergency assessment. Acute poisoning takes priority over questions about dependence, rehabilitation, or recovery.

What is trazodone?

Clinical perspective

Trazodone started off as an antidepressant, and the sedation that used to be considered a side effect is the entire reason it's prescribed today. It's one of the go-to non-habit-forming options for sleep, especially for someone with a substance use history where dependence potential needs to be avoided.

Trazodone is a prescription serotonin antagonist and reuptake inhibitor approved by the FDA to treat major depressive disorder in adults. It affects serotonin transport and receptors, blocks histamine and alpha-1 adrenergic receptors, and can produce drowsiness and lower blood pressure.

Clinicians also prescribe trazodone off label for insomnia, but FDA approval applies to major depressive disorder rather than sleep treatment. Approved indication, common off-label use, and individual treatment benefit are three different questions.

Trazodone belongs within the broader topic of prescription drug use and misuse, but it is not a benzodiazepine, opioid, or federally controlled substance. Its regulatory status does not eliminate poisoning or interaction risk.

Does trazodone have known addiction potential?

Available evidence does not establish a trazodone-specific addiction rate or predictable addiction syndrome, but compulsive and harmful misuse still warrants clinical assessment. The FDA states that trazodone is not controlled, has not been systematically studied for abuse potential, and showed no drug-seeking behavior in its clinical studies.

Those findings do not prove that misuse never occurs. They mean the page should not assign trazodone a fabricated "moderate" addiction potential or assume that everyone who increases a dose has developed addiction.

How do trazodone misuse, dependence, and discontinuation differ?

Misuse is taking trazodone in a way other than directed, physiological adaptation is the body's response to repeated exposure, and addiction is impaired control with continued harmful use. A patient can experience discontinuation symptoms after therapeutic use without craving, drug seeking, or a substance use disorder.

Examples of misuse include taking extra tablets for stronger sedation, using another person's prescription, or combining trazodone with other substances for intoxication. None of those actions alone determines severity; clinicians assess frequency, intent, consequences, and control.

When does trazodone misuse become a treatment concern?

Trazodone misuse becomes a treatment concern when use is difficult to control, creates hazardous exposure, or continues despite physical or functional harm. Drowsiness or dizziness after a prescribed dose may be an adverse effect rather than evidence of compulsive use.

• Impaired control: repeatedly taking more trazodone than intended or failing to follow a planned reduction.
• Nonmedical purpose: using the prescription primarily to intensify sedation, emotional numbing, or another substance's effects.
• Hazardous use: driving while impaired, mixing depressants, or using medication from an unregulated source.
• Functional harm: missing responsibilities, withdrawing from relationships, or continuing after falls and medical warnings.
• Expected adverse effects: sleepiness, dizziness, dry mouth, constipation, and blurred vision can occur without misuse.
• Acute toxicity: profound sedation, fainting, irregular heartbeat, seizure, or breathing difficulty indicates possible poisoning rather than a diagnostic addiction sign.

How does trazodone affect the brain and body?

Trazodone inhibits serotonin transport, blocks selected serotonin receptors, and antagonizes histamine and alpha-1 adrenergic receptors. These actions can support antidepressant effects, cause sedation, and contribute to dizziness or orthostatic hypotension.

Trazodone is metabolized primarily through CYP3A4 to the active metabolite meta-chlorophenylpiperazine, or mCPP. Its relationship to serotonin signaling helps explain therapeutic effects and serotonin-syndrome risk; it does not prove that normal serotonergic treatment activates an addiction cycle.

Which trazodone interactions are dangerous?

Serotonergic combinations can contribute to serotonin syndrome, central nervous system depressants can deepen impairment, and QT-prolonging combinations can increase cardiac risk. Trazodone is contraindicated with an MAOI and within 14 days after an MAOI is stopped.

Serotonin syndrome can involve mental-status change, autonomic instability, and neuromuscular abnormalities. Agitation or confusion, fever or unstable blood pressure, and tremor or rigidity require urgent assessment, especially after a dose change or addition of another serotonergic medicine.

Alcohol use can compound trazodone sedation, impaired judgment, and fall risk. Barbiturates, benzodiazepines, opioids, sleep medicines, and other depressants can add further central nervous system effects.

Strong CYP3A4 inhibitors can raise trazodone exposure, CYP3A4 inducers can lower it, and other QT-prolonging drugs can increase arrhythmia risk. A pharmacist or prescriber should review prescriptions, over-the-counter products, and supplements before the dose or combination changes.

What serious adverse effects can trazodone cause?

Serious trazodone adverse effects include cardiac arrhythmia, orthostatic hypotension or syncope, and priapism. FDA labeling also warns about bleeding, hyponatremia, activation of mania or hypomania, and cognitive or motor impairment.

A painful or prolonged erection requires immediate medical attention because delay can cause permanent injury. Fainting or an irregular heartbeat, severe confusion or seizure, and rapidly worsening agitation or suicidal thinking also require urgent evaluation.

The boxed warning concerns increased suicidal thoughts and behaviors in pediatric and young adult patients taking antidepressants. It calls for monitoring during treatment initiation and dose changes; it should not be misrepresented as evidence that trazodone misuse inevitably causes suicidality.

What are the signs of a trazodone overdose?

Trazodone overdose commonly causes drowsiness and vomiting, while severe poisoning can cause respiratory arrest, seizures, priapism, or ECG changes including QT prolongation. Deaths have occurred after trazodone was taken with alcohol and other central nervous system depressants.

Call 911 when a person cannot be awakened, breathes abnormally, collapses, has a seizure, or develops another life-threatening symptom. For a suspected extra or accidental dose without those immediate danger signs, contact Poison Help at 1-800-222-1222; do not induce vomiting.

No specific antidote reverses trazodone. Emergency clinicians support airway and breathing, monitor cardiac rhythm and vital signs, and assess co-ingested substances because the medication, the dose, and the combination determine risk.

What happens when trazodone is stopped?

Trazodone discontinuation syndrome can cause nausea, sweating, irritability, dizziness, anxiety, and sleep disturbance, especially after abrupt cessation. Reported reactions also include sensory disturbances, tremor, confusion, headache, emotional lability, hypomania, tinnitus, and seizures.

FDA labeling recommends gradual dose reduction whenever possible. Drug withdrawal varies by medication class, while trazodone reduction depends on dose, treatment duration, underlying depression, and previous discontinuation response.

Discontinuation symptoms do not establish addiction. Physiological adaptation affects how a medication is reduced, while addiction treatment addresses craving, impaired control, hazardous use, and harmful persistence.

How is harmful trazodone misuse assessed?

Assessment separates therapeutic use, nonmedical misuse, discontinuation syndrome, and substance use disorder. A clinician evaluates control over use, reasons for taking trazodone, consequences, and daily function rather than diagnosing addiction from one symptom.

The review includes prescribed and actual dose, access to the medication, other substances, attempts to stop, intoxication or overdose history, and co-occurring sleep or mood symptoms. Cardiac history, seizure risk, suicide risk, and possible serotonin syndrome determine whether immediate medical care comes before a behavioral assessment.

How is harmful trazodone misuse treated?

Trazodone-related treatment first stabilizes poisoning or severe adverse effects, then manages discontinuation safely, and then addresses compulsive use when a substance use disorder is present. A person taking trazodone therapeutically may need only medication management, while a person with impaired control may need behavioral treatment and continuing recovery support.

No medication is FDA-approved specifically for trazodone-related compulsive use. Buprenorphine, methadone, and naltrexone should not be presented as trazodone treatments; medications for depression, sleep, or another substance use disorder address their own diagnosed indications.

After medical stabilization, a structured prescription drug addiction treatment program can provide assessment, behavioral therapy, co-occurring care, rehabilitation planning, and recovery support. Treatment intensity should follow safety, function, environment, and response rather than a generic inpatient-versus-outpatient table.

Does trazodone show up on a drug test?

Trazodone's mCPP metabolite can cross-react with the Roche Amphetamines II immunoassay, so an initial positive result can require confirmatory testing. A 2011 Journal of Analytical Toxicology study demonstrated that assay-specific interference in samples containing mCPP but no confirmed amphetamine, methamphetamine, or MDMA.

An initial immunoassay is presumptive, confirmatory mass spectrometry distinguishes the compounds, and the testing laboratory interprets the assay used. A person with an unexpected result should disclose prescribed trazodone and request confirmation rather than assume the medication always will or never will affect a screen.

What are common questions about trazodone?

Common trazodone questions concern sleep use, medication treatment, and emergency adverse effects. The answers depend on indication, use pattern, and current symptoms.

Is trazodone approved for insomnia?

No. Trazodone is FDA-approved for major depressive disorder, although clinicians frequently prescribe it off label for insomnia. Off-label prescribing can be medically appropriate, but the prescriber should assess benefit, sedation, interactions, and alternatives.

Alcohol can make a person feel sleepy without producing the same sleep pattern or safety profile. Alcohol's effects on sleep include shorter sleep onset alongside later fragmentation, while combining alcohol with trazodone adds sedation and impairment risk.

Is there medication-assisted treatment for harmful trazodone misuse?

No medication is FDA-approved specifically for trazodone use disorder. Clinicians may treat depression, discontinuation symptoms, or another substance use disorder with condition-specific care, but those treatments should not be mislabeled as a trazodone addiction medication.

When is trazodone-related priapism an emergency?

A painful or prolonged erection requires immediate medical attention. Waiting for it to resolve can delay treatment and increase the risk of permanent tissue injury.